<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Nephrology Now &#187; Lupus</title>
	<atom:link href="http://www.nephrologynow.com/publications/category/lupus/feed" rel="self" type="application/rss+xml" />
	<link>http://www.nephrologynow.com</link>
	<description></description>
	<lastBuildDate>Tue, 20 Jul 2010 07:46:28 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<script type="text/javascript">

if (typeof Meebo == 'undefined') {

Meebo=function(){(Meebo._=Meebo._||[]).push(arguments)};
(function(q){

	var args = arguments;
	if (!document.body) { return setTimeout(function(){ args.callee.apply(this, args) }, 100); }
	var d=document, b=d.body, m=b.insertBefore(d.createElement('div'), b.firstChild); s=d.createElement('script');
	m.id='meebo'; m.style.display='none'; m.innerHTML='<iframe id="meebo-iframe"></iframe>';
	s.src='http'+(q.https?'s':'')+'://'+(q.stage?'stage-':'')+'cim.meebo.com/cim/cim.php?network='+q.network;
	b.insertBefore(s, b.firstChild);

})({network:'nephrologynow_bi16va'});	}</script>	<item>
		<title>Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis</title>
		<link>http://www.nephrologynow.com/publications/mycophenolate-mofetil-and-intravenous-cyclophosphamide-are-similar-as-induction-therapy-for-class-v-lupus-nephritis</link>
		<comments>http://www.nephrologynow.com/publications/mycophenolate-mofetil-and-intravenous-cyclophosphamide-are-similar-as-induction-therapy-for-class-v-lupus-nephritis#comments</comments>
		<pubDate>Tue, 12 Jan 2010 01:02:25 +0000</pubDate>
		<dc:creator>Nephrology Now editors</dc:creator>
				<category><![CDATA[Glomerulonephritis]]></category>
		<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com/?p=1322</guid>
		<description><![CDATA[Results of two randomized trial using induction treatment with either MMF or intravenous cyclophosphamide were pooled in this article. At 24 weeks, the results show that both groups were similar with respect to percentage change in proteinuria and serum creatinine as end points when used to treat patients with class V lupus.Related Articles:

Mycophenolate mofetil versus [...]]]></description>
			<content:encoded><![CDATA[<p>Results of two randomized trial using induction treatment with either MMF or intravenous cyclophosphamide were pooled in this article. At 24 weeks, the results show that both groups were similar with respect to percentage change in proteinuria and serum creatinine as end points when used to treat patients with class V lupus.<strong>Related Articles:</strong>
<ul class="similar-posts">
<li><a href="http://www.nephrologynow.com/publications/mycophenolate-mofetil-versus-cyclophosphamide-for-induction-treatment-of-lupus-nephritis" rel="bookmark" title="May 2, 2009">Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.</a></li>
<li><a href="http://www.nephrologynow.com/publications/randomized-controlled-trial-of-prednisone-cyclophosphamide-and-cyclosporine-in-lupus-membranous-nephropathy" rel="bookmark" title="April 1, 2009">Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy.</a></li>
<li><a href="http://www.nephrologynow.com/publications/proteinuria-reducing-effects-of-tonsillectomy-alone-in-iga-nephropathy-recurring-after-kidney-transplantation" rel="bookmark" title="November 22, 2009">Proteinuria-Reducing Effects of Tonsillectomy Alone in IgA Nephropathy Recurring After Kidney Transplantation</a></li>
</ul>
<p><!-- Similar Posts took 25.783 ms --></p>
<img style='display:none' id="post-1322-blankimage" onload="Meebo('discoverSharable', {element: ((this.parentNode.className.match('post')) ? this.parentNode : this.parentNode.parentNode) ,url:'http://www.nephrologynow.com/publications/mycophenolate-mofetil-and-intravenous-cyclophosphamide-are-similar-as-induction-therapy-for-class-v-lupus-nephritis',title:'Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis',tweet:'Results of two randomized trial using induction treatment with either MMF or intravenous cyclophosph',description:'Results of two randomized trial using induction treatment with either MMF or intravenous cyclophosph'})"><script type='text/javascript'></script>]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/mycophenolate-mofetil-and-intravenous-cyclophosphamide-are-similar-as-induction-therapy-for-class-v-lupus-nephritis/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.</title>
		<link>http://www.nephrologynow.com/publications/mycophenolate-mofetil-is-as-efficacious-as-but-safer-than-cyclophosphamide-in-the-treatment-of-proliferative-lupus-nephritis-a-meta-analysis-and-meta-regression</link>
		<comments>http://www.nephrologynow.com/publications/mycophenolate-mofetil-is-as-efficacious-as-but-safer-than-cyclophosphamide-in-the-treatment-of-proliferative-lupus-nephritis-a-meta-analysis-and-meta-regression#comments</comments>
		<pubDate>Mon, 19 Oct 2009 03:34:43 +0000</pubDate>
		<dc:creator>Nephrology Now editors</dc:creator>
				<category><![CDATA[Glomerulonephritis]]></category>
		<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com/?p=1189</guid>
		<description><![CDATA[This meta-analysis suggests that for the treatment of proliferative lupus nephritis, MMF offers similar efficacy in renal remission and survival as cyclophosphamide with a better safety profile.Related Articles:

Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Randomized, Controlled [...]]]></description>
			<content:encoded><![CDATA[<p>This meta-analysis suggests that for the treatment of proliferative lupus nephritis, MMF offers similar efficacy in renal remission and survival as cyclophosphamide with a better safety profile.<strong>Related Articles:</strong>
<ul class="similar-posts">
<li><a href="http://www.nephrologynow.com/publications/rituximab-and-mycophenolate-mofetil-for-relapsing-proliferative-lupus-nephritis-a-long-term-prospective-study" rel="bookmark" title="July 10, 2009">Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study</a></li>
<li><a href="http://www.nephrologynow.com/publications/mycophenolate-mofetil-and-intravenous-cyclophosphamide-are-similar-as-induction-therapy-for-class-v-lupus-nephritis" rel="bookmark" title="January 11, 2010">Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis</a></li>
<li><a href="http://www.nephrologynow.com/publications/randomized-controlled-trial-of-prednisone-cyclophosphamide-and-cyclosporine-in-lupus-membranous-nephropathy" rel="bookmark" title="April 1, 2009">Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy.</a></li>
</ul>
<p><!-- Similar Posts took 6.825 ms --></p>
<img style='display:none' id="post-1189-blankimage" onload="Meebo('discoverSharable', {element: ((this.parentNode.className.match('post')) ? this.parentNode : this.parentNode.parentNode) ,url:'http://www.nephrologynow.com/publications/mycophenolate-mofetil-is-as-efficacious-as-but-safer-than-cyclophosphamide-in-the-treatment-of-proliferative-lupus-nephritis-a-meta-analysis-and-meta-regression',title:'Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.',tweet:'This meta-analysis suggests that for the treatment of proliferative lupus nephritis, MMF offers simi',description:'This meta-analysis suggests that for the treatment of proliferative lupus nephritis, MMF offers simi'})"><script type='text/javascript'></script>]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/mycophenolate-mofetil-is-as-efficacious-as-but-safer-than-cyclophosphamide-in-the-treatment-of-proliferative-lupus-nephritis-a-meta-analysis-and-meta-regression/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study</title>
		<link>http://www.nephrologynow.com/publications/rituximab-and-mycophenolate-mofetil-for-relapsing-proliferative-lupus-nephritis-a-long-term-prospective-study</link>
		<comments>http://www.nephrologynow.com/publications/rituximab-and-mycophenolate-mofetil-for-relapsing-proliferative-lupus-nephritis-a-long-term-prospective-study#comments</comments>
		<pubDate>Fri, 10 Jul 2009 05:23:41 +0000</pubDate>
		<dc:creator>Nephrology Now editors</dc:creator>
				<category><![CDATA[Glomerulonephritis]]></category>
		<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com/?p=978</guid>
		<description><![CDATA[This prospective, observational study looked 10 women with subnephrotic proliferative lupus nephritis who relapsed on maintenance MMF or Imuran. They were treated with 4 weekly infusions of rituximab combined with MMF and prednisolone. This combination was found to have low toxicity and 7 patients were found to have a complete remission. This seems to warrant [...]]]></description>
			<content:encoded><![CDATA[<p>This prospective, observational study looked 10 women with subnephrotic proliferative lupus nephritis who relapsed on maintenance MMF or Imuran. They were treated with 4 weekly infusions of rituximab combined with MMF and prednisolone. This combination was found to have low toxicity and 7 patients were found to have a complete remission. This seems to warrant further study in a randomized controlled trial.<strong>Related Articles:</strong>
<ul class="similar-posts">
<li><a href="http://www.nephrologynow.com/publications/mycophenolate-mofetil-is-as-efficacious-as-but-safer-than-cyclophosphamide-in-the-treatment-of-proliferative-lupus-nephritis-a-meta-analysis-and-meta-regression" rel="bookmark" title="October 18, 2009">Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.</a></li>
<li><a href="http://www.nephrologynow.com/publications/mycophenolate-mofetil-versus-cyclophosphamide-for-induction-treatment-of-lupus-nephritis" rel="bookmark" title="May 2, 2009">Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.</a></li>
<li><a href="http://www.nephrologynow.com/publications/recurrent-idiopathic-membranous-nephropathy-early-diagnosis-by-protocol-biopsies-and-treatment-with-anti-cd20-monoclonal-antibodies" rel="bookmark" title="December 14, 2009">Recurrent Idiopathic Membranous Nephropathy: Early Diagnosis by Protocol Biopsies and Treatment with Anti-Cd20 Monoclonal Antibodies</a></li>
</ul>
<p><!-- Similar Posts took 32.715 ms --></p>
<img style='display:none' id="post-978-blankimage" onload="Meebo('discoverSharable', {element: ((this.parentNode.className.match('post')) ? this.parentNode : this.parentNode.parentNode) ,url:'http://www.nephrologynow.com/publications/rituximab-and-mycophenolate-mofetil-for-relapsing-proliferative-lupus-nephritis-a-long-term-prospective-study',title:'Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study',tweet:'This prospective, observational study looked 10 women with subnephrotic proliferative lupus nephriti',description:'This prospective, observational study looked 10 women with subnephrotic proliferative lupus nephriti'})"><script type='text/javascript'></script>]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/rituximab-and-mycophenolate-mofetil-for-relapsing-proliferative-lupus-nephritis-a-long-term-prospective-study/feed</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.</title>
		<link>http://www.nephrologynow.com/publications/mycophenolate-mofetil-versus-cyclophosphamide-for-induction-treatment-of-lupus-nephritis</link>
		<comments>http://www.nephrologynow.com/publications/mycophenolate-mofetil-versus-cyclophosphamide-for-induction-treatment-of-lupus-nephritis#comments</comments>
		<pubDate>Sat, 02 May 2009 22:31:54 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/?p=840</guid>
		<description><![CDATA[This study randomized 370 patients with class III to V lupus nephritis to MMF or intravenous cyclophosphamide during a 24-week induction period. Both groups received a tapering dose of prednisone. No difference in response rate was detected between groups.Related Articles:

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Pulse versus [...]]]></description>
			<content:encoded><![CDATA[<p>This study randomized 370 patients with class III to V lupus nephritis to MMF or intravenous cyclophosphamide during a 24-week induction period. Both groups received a tapering dose of prednisone. No difference in response rate was detected between groups.<strong>Related Articles:</strong>
<ul class="similar-posts">
<li><a href="http://www.nephrologynow.com/publications/mycophenolate-mofetil-and-intravenous-cyclophosphamide-are-similar-as-induction-therapy-for-class-v-lupus-nephritis" rel="bookmark" title="January 11, 2010">Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis</a></li>
<li><a href="http://www.nephrologynow.com/publications/pulse-versus-daily-oral-cyclophosphamide-for-induction-of-remission-in-antineutrophil-cytoplasmic-antibody%e2%80%94associated-vasculitis" rel="bookmark" title="May 2, 2009">Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody—associated vasculitis.</a></li>
<li><a href="http://www.nephrologynow.com/publications/randomized-controlled-trial-of-prednisone-cyclophosphamide-and-cyclosporine-in-lupus-membranous-nephropathy" rel="bookmark" title="April 1, 2009">Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy.</a></li>
</ul>
<p><!-- Similar Posts took 8.794 ms --></p>
<img style='display:none' id="post-840-blankimage" onload="Meebo('discoverSharable', {element: ((this.parentNode.className.match('post')) ? this.parentNode : this.parentNode.parentNode) ,url:'http://www.nephrologynow.com/publications/mycophenolate-mofetil-versus-cyclophosphamide-for-induction-treatment-of-lupus-nephritis',title:'Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.',tweet:'This study randomized 370 patients with class III to V lupus nephritis to MMF or intravenous cycloph',description:'This study randomized 370 patients with class III to V lupus nephritis to MMF or intravenous cycloph'})"><script type='text/javascript'></script>]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/mycophenolate-mofetil-versus-cyclophosphamide-for-induction-treatment-of-lupus-nephritis/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy.</title>
		<link>http://www.nephrologynow.com/publications/randomized-controlled-trial-of-prednisone-cyclophosphamide-and-cyclosporine-in-lupus-membranous-nephropathy</link>
		<comments>http://www.nephrologynow.com/publications/randomized-controlled-trial-of-prednisone-cyclophosphamide-and-cyclosporine-in-lupus-membranous-nephropathy#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/randomized-controlled-trial-of-prednisone-cyclophosphamide-and-cyclosporine-in-lupus-membranous-nephropathy</guid>
		<description><![CDATA[This study randomized patients with lupus membranous nephropathy to prednisone, cyclophosphamide or cyclosporine. Regimens containing cyclosporine or cyclophosphamide were each more effective than prednisone alone in inducing remission of proteinuria among such patients.Related Articles:

Proteinuria-Reducing Effects of Tonsillectomy Alone in IgA Nephropathy Recurring After Kidney Transplantation
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
Recurrent Idiopathic [...]]]></description>
			<content:encoded><![CDATA[<p>This study randomized patients with lupus membranous nephropathy to prednisone, cyclophosphamide or cyclosporine. Regimens containing cyclosporine or cyclophosphamide were each more effective than prednisone alone in inducing remission of proteinuria among such patients.<strong>Related Articles:</strong>
<ul class="similar-posts">
<li><a href="http://www.nephrologynow.com/publications/proteinuria-reducing-effects-of-tonsillectomy-alone-in-iga-nephropathy-recurring-after-kidney-transplantation" rel="bookmark" title="November 22, 2009">Proteinuria-Reducing Effects of Tonsillectomy Alone in IgA Nephropathy Recurring After Kidney Transplantation</a></li>
<li><a href="http://www.nephrologynow.com/publications/mycophenolate-mofetil-versus-cyclophosphamide-for-induction-treatment-of-lupus-nephritis" rel="bookmark" title="May 2, 2009">Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.</a></li>
<li><a href="http://www.nephrologynow.com/publications/recurrent-idiopathic-membranous-nephropathy-early-diagnosis-by-protocol-biopsies-and-treatment-with-anti-cd20-monoclonal-antibodies" rel="bookmark" title="December 14, 2009">Recurrent Idiopathic Membranous Nephropathy: Early Diagnosis by Protocol Biopsies and Treatment with Anti-Cd20 Monoclonal Antibodies</a></li>
</ul>
<p><!-- Similar Posts took 11.566 ms --></p>
<img style='display:none' id="post-766-blankimage" onload="Meebo('discoverSharable', {element: ((this.parentNode.className.match('post')) ? this.parentNode : this.parentNode.parentNode) ,url:'http://www.nephrologynow.com/publications/randomized-controlled-trial-of-prednisone-cyclophosphamide-and-cyclosporine-in-lupus-membranous-nephropathy',title:'Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy.',tweet:'This study randomized patients with lupus membranous nephropathy to prednisone, cyclophosphamide or ',description:'This study randomized patients with lupus membranous nephropathy to prednisone, cyclophosphamide or '})"><script type='text/javascript'></script>]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/randomized-controlled-trial-of-prednisone-cyclophosphamide-and-cyclosporine-in-lupus-membranous-nephropathy/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Treatment of Membranous Lupus Nephritis: Where Are We Now?</title>
		<link>http://www.nephrologynow.com/publications/treatment-of-membranous-lupus-nephritis-where-are-we-now</link>
		<comments>http://www.nephrologynow.com/publications/treatment-of-membranous-lupus-nephritis-where-are-we-now#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/treatment-of-membranous-lupus-nephritis-where-are-we-now</guid>
		<description><![CDATA[Related Articles:

Why are rheumatologists treating lupus nephritis?
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Update on the Treatment of Lupus Nephritis


]]></description>
			<content:encoded><![CDATA[Related Articles:

Why are rheumatologists treating lupus nephritis?
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Update on the Treatment of Lupus Nephritis


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/treatment-of-membranous-lupus-nephritis-where-are-we-now/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma.</title>
		<link>http://www.nephrologynow.com/publications/membranous-nephropathy-in-systemic-lupus-erythematosus-a-therapeutic-enigma</link>
		<comments>http://www.nephrologynow.com/publications/membranous-nephropathy-in-systemic-lupus-erythematosus-a-therapeutic-enigma#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/membranous-nephropathy-in-systemic-lupus-erythematosus-a-therapeutic-enigma</guid>
		<description><![CDATA[Related Articles:

Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy.
Dual inhibition with losartan and aliskiren: a promising therapeutic option for type 2 diabetic nephropathy?


]]></description>
			<content:encoded><![CDATA[Related Articles:

Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy.
Dual inhibition with losartan and aliskiren: a promising therapeutic option for type 2 diabetic nephropathy?


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/membranous-nephropathy-in-systemic-lupus-erythematosus-a-therapeutic-enigma/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.</title>
		<link>http://www.nephrologynow.com/publications/tacrolimus-for-the-treatment-of-systemic-lupus-erythematosus-with-pure-class-v-nephritis</link>
		<comments>http://www.nephrologynow.com/publications/tacrolimus-for-the-treatment-of-systemic-lupus-erythematosus-with-pure-class-v-nephritis#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/tacrolimus-for-the-treatment-of-systemic-lupus-erythematosus-with-pure-class-v-nephritis</guid>
		<description><![CDATA[Related Articles:

Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy.
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma.


]]></description>
			<content:encoded><![CDATA[Related Articles:

Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy.
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma.


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/tacrolimus-for-the-treatment-of-systemic-lupus-erythematosus-with-pure-class-v-nephritis/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy.</title>
		<link>http://www.nephrologynow.com/publications/successful-treatment-of-class-viv-lupus-nephritis-with-multitarget-therapy</link>
		<comments>http://www.nephrologynow.com/publications/successful-treatment-of-class-viv-lupus-nephritis-with-multitarget-therapy#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/successful-treatment-of-class-viv-lupus-nephritis-with-multitarget-therapy</guid>
		<description><![CDATA[Related Articles:

Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.


]]></description>
			<content:encoded><![CDATA[Related Articles:

Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/successful-treatment-of-class-viv-lupus-nephritis-with-multitarget-therapy/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Multitarget therapy of lupus nephritis: base hit or home run?</title>
		<link>http://www.nephrologynow.com/publications/multitarget-therapy-of-lupus-nephritis-base-hit-or-home-run</link>
		<comments>http://www.nephrologynow.com/publications/multitarget-therapy-of-lupus-nephritis-base-hit-or-home-run#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Glomerulonephritis]]></category>
		<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/multitarget-therapy-of-lupus-nephritis-base-hit-or-home-run</guid>
		<description><![CDATA[Related Articles:

Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy.
Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis


]]></description>
			<content:encoded><![CDATA[Related Articles:

Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy.
Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/multitarget-therapy-of-lupus-nephritis-base-hit-or-home-run/feed</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>How did cyclophosphamide become the drug of choice for lupus nephritis?</title>
		<link>http://www.nephrologynow.com/publications/how-did-cyclophosphamide-become-the-drug-of-choice-for-lupus-nephritis</link>
		<comments>http://www.nephrologynow.com/publications/how-did-cyclophosphamide-become-the-drug-of-choice-for-lupus-nephritis#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/how-did-cyclophosphamide-become-the-drug-of-choice-for-lupus-nephritis</guid>
		<description><![CDATA[Related Articles:

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis


]]></description>
			<content:encoded><![CDATA[Related Articles:

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/how-did-cyclophosphamide-become-the-drug-of-choice-for-lupus-nephritis/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.</title>
		<link>http://www.nephrologynow.com/publications/induction-therapies-for-class-iv-lupus-nephritis-with-non-inflammatory-necrotizing-vasculopathy-mycophenolate-mofetil-or-intravenous-cyclophosphamide</link>
		<comments>http://www.nephrologynow.com/publications/induction-therapies-for-class-iv-lupus-nephritis-with-non-inflammatory-necrotizing-vasculopathy-mycophenolate-mofetil-or-intravenous-cyclophosphamide#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/induction-therapies-for-class-iv-lupus-nephritis-with-non-inflammatory-necrotizing-vasculopathy-mycophenolate-mofetil-or-intravenous-cyclophosphamide</guid>
		<description><![CDATA[Related Articles:

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis


]]></description>
			<content:encoded><![CDATA[Related Articles:

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/induction-therapies-for-class-iv-lupus-nephritis-with-non-inflammatory-necrotizing-vasculopathy-mycophenolate-mofetil-or-intravenous-cyclophosphamide/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis</title>
		<link>http://www.nephrologynow.com/publications/mycophenolate-mofetil-for-induction-therapy-of-lupus-nephritis-a-systematic-review-and-meta-analysis</link>
		<comments>http://www.nephrologynow.com/publications/mycophenolate-mofetil-for-induction-therapy-of-lupus-nephritis-a-systematic-review-and-meta-analysis#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/mycophenolate-mofetil-for-induction-therapy-of-lupus-nephritis-a-systematic-review-and-meta-analysis</guid>
		<description><![CDATA[Related Articles:

Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.


]]></description>
			<content:encoded><![CDATA[Related Articles:

Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/mycophenolate-mofetil-for-induction-therapy-of-lupus-nephritis-a-systematic-review-and-meta-analysis/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Outcomes in Patients with Active Lupus Nephritis Requiring Immunosuppressives Who Never Received Cyclophosphamide.</title>
		<link>http://www.nephrologynow.com/publications/outcomes-in-patients-with-active-lupus-nephritis-requiring-immunosuppressives-who-never-received-cyclophosphamide</link>
		<comments>http://www.nephrologynow.com/publications/outcomes-in-patients-with-active-lupus-nephritis-requiring-immunosuppressives-who-never-received-cyclophosphamide#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/outcomes-in-patients-with-active-lupus-nephritis-requiring-immunosuppressives-who-never-received-cyclophosphamide</guid>
		<description><![CDATA[Related Articles:

Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
How did cyclophosphamide become the drug of choice for lupus nephritis?
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.


]]></description>
			<content:encoded><![CDATA[Related Articles:

Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
How did cyclophosphamide become the drug of choice for lupus nephritis?
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/outcomes-in-patients-with-active-lupus-nephritis-requiring-immunosuppressives-who-never-received-cyclophosphamide/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.</title>
		<link>http://www.nephrologynow.com/publications/mycophenolate-mofetil-in-induction-and-maintenance-therapy-of-severe-lupus-nephritis-a-meta-analysis-of-randomized-controlled-trials</link>
		<comments>http://www.nephrologynow.com/publications/mycophenolate-mofetil-in-induction-and-maintenance-therapy-of-severe-lupus-nephritis-a-meta-analysis-of-randomized-controlled-trials#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/mycophenolate-mofetil-in-induction-and-maintenance-therapy-of-severe-lupus-nephritis-a-meta-analysis-of-randomized-controlled-trials</guid>
		<description><![CDATA[Related Articles:

Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis


]]></description>
			<content:encoded><![CDATA[Related Articles:

Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/mycophenolate-mofetil-in-induction-and-maintenance-therapy-of-severe-lupus-nephritis-a-meta-analysis-of-randomized-controlled-trials/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why are rheumatologists treating lupus nephritis?</title>
		<link>http://www.nephrologynow.com/publications/why-are-rheumatologists-treating-lupus-nephritis</link>
		<comments>http://www.nephrologynow.com/publications/why-are-rheumatologists-treating-lupus-nephritis#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/why-are-rheumatologists-treating-lupus-nephritis</guid>
		<description><![CDATA[Related Articles:

Treatment of Membranous Lupus Nephritis: Where Are We Now?
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Update on the Treatment of Lupus Nephritis


]]></description>
			<content:encoded><![CDATA[Related Articles:

Treatment of Membranous Lupus Nephritis: Where Are We Now?
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Update on the Treatment of Lupus Nephritis


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/why-are-rheumatologists-treating-lupus-nephritis/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.</title>
		<link>http://www.nephrologynow.com/publications/histopathologic-and-clinical-outcome-of-rituximab-treatment-in-patients-with-cyclophosphamide-resistant-proliferative-lupus-nephritis</link>
		<comments>http://www.nephrologynow.com/publications/histopathologic-and-clinical-outcome-of-rituximab-treatment-in-patients-with-cyclophosphamide-resistant-proliferative-lupus-nephritis#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/histopathologic-and-clinical-outcome-of-rituximab-treatment-in-patients-with-cyclophosphamide-resistant-proliferative-lupus-nephritis</guid>
		<description><![CDATA[Related Articles:

Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.
Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.


]]></description>
			<content:encoded><![CDATA[Related Articles:

Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.
Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/histopathologic-and-clinical-outcome-of-rituximab-treatment-in-patients-with-cyclophosphamide-resistant-proliferative-lupus-nephritis/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Update on the Treatment of Lupus Nephritis</title>
		<link>http://www.nephrologynow.com/publications/update-on-the-treatment-of-lupus-nephritis</link>
		<comments>http://www.nephrologynow.com/publications/update-on-the-treatment-of-lupus-nephritis#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/update-on-the-treatment-of-lupus-nephritis</guid>
		<description><![CDATA[Related Articles:

Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
Treatment of Membranous Lupus Nephritis: Where Are We Now?
Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy.


]]></description>
			<content:encoded><![CDATA[Related Articles:

Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
Treatment of Membranous Lupus Nephritis: Where Are We Now?
Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy.


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/update-on-the-treatment-of-lupus-nephritis/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.</title>
		<link>http://www.nephrologynow.com/publications/azathioprinemethylprednisolone-versus-cyclophosphamide-in-proliferative-lupus-nephritis-a-randomized-controlled-trial</link>
		<comments>http://www.nephrologynow.com/publications/azathioprinemethylprednisolone-versus-cyclophosphamide-in-proliferative-lupus-nephritis-a-randomized-controlled-trial#comments</comments>
		<pubDate>Tue, 30 Nov 1999 05:00:00 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Lupus]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com.s65750.gridserver.com/publications/azathioprinemethylprednisolone-versus-cyclophosphamide-in-proliferative-lupus-nephritis-a-randomized-controlled-trial</guid>
		<description><![CDATA[Related Articles:

Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.
Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy.


]]></description>
			<content:encoded><![CDATA[Related Articles:

Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.
Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy.


]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/azathioprinemethylprednisolone-versus-cyclophosphamide-in-proliferative-lupus-nephritis-a-randomized-controlled-trial/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
